UK-based Eagle Genomics has appointed Anthony Finbow as its new executive chairman.
He succeeds Alan Barrell in the role, with Barrell becoming a non-executive director at the life sciences research firm.
Finbow had previously been working in an advisory capacity at Eagle Genomics, assisting chief executive officer Abel Ureta-Vidal with business development.
Ureta-Vidal said: “Anthony’s arrival has been transformative for Eagle Genomics. He has been pushing the boundaries of the business and the management team to come up with innovative products opening up unsuspected opportunities.
“I am happy to have him my side and I’m confident that the coming years will be the most exciting for the Eagle Genomics business.”
Finbow brings over 20 years of senior leadership experience to the firm, and currently serves as chief executive officer at Solv Ltd, a leadership development business.
He has worked at several software firms, including Orchestream where he was chief executive officer and MetaSolv Software as its managing director.
He said: “I am delighted to have been invited to become executive chairman at Eagle Genomics at this formative stage in the company’s development.
“In the short time that I have been involved with the business, we have achieved exciting progress, including the securing of our most significant software sale to date and the development, with launch customers, of a new family of products, to be announced shortly.”